A Preclinical Systematic Review of Ginsenoside-Rg1 in Experimental Parkinson's Disease

To date, no drug has been proven to be neuroprotective or disease-modifying for Parkinson's disease (PD) in clinical trials. Here, we aimed to assess preclinical evidence of Ginsenosides-Rg1 (G-Rg1), a potential neuroprotectant, for experimental PD and its possible mechanisms. Eligible studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Liang, Xu, Meng-Bei, Zhou, Xiao-Li, Zhang, Dao-pei, Zhang, Shu-ling, Zheng, Guo-qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366755/
https://www.ncbi.nlm.nih.gov/pubmed/28386306
http://dx.doi.org/10.1155/2017/2163053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366755/
https://www.ncbi.nlm.nih.gov/pubmed/28386306
http://dx.doi.org/10.1155/2017/2163053

Ejemplares similares